Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LIV by WellNow vs Primary Clinic (Direct GLP)

LIV by WellNow
Graded #264

Lower grade

vs+5.800000000000004
Primary Clinic (Direct GLP)
Graded #144

Higher grade

The verdict

Primary Clinic (Direct GLP) takes it — 68.7/100 to 62.9/100.

Primary Clinic (Direct GLP) grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Primary Clinic (Direct GLP) is a Direct Primary Care membership rather than the usual direct-to-consumer GLP-1 marketplace.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePrimary Clinic (Direct GLP) +27
51
78
Dose & formulationLIV by WellNow +19
73
54
Clinical oversightLIV by WellNow +4
79
75
Labs & monitoringPrimary Clinic (Direct GLP) +24
52
76
FulfillmentPrimary Clinic (Direct GLP) +10
63
73
Contract termsLIV by WellNow +14
55
41
LIV by WellNow · left barPrimary Clinic (Direct GLP) · right bar

The numbers

MetricLIV by WellNowPrimary Clinic (Direct GLP)
WeighScore62.9/10068.7/100
GradeCC
Scorecard rank#264#144
Semaglutide$279/mo$65/mo (0.25 mg dose, promotional rate, compounded)
TirzepatideNot disclosed$110/mo (2.5 mg dose, promotional rate, compounded)
Coverage5 states10 states
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
LIV by WellNow

Graded #264 · C

Strengths

  • Flat $279/month covers medication, supplies, and unlimited virtual visits
  • Backed by established WellNow Urgent Care brand
  • Board-certified online medical providers
  • Same-day approval and monthly home delivery
  • Transparent all-inclusive pricing with no hidden fees

Where it loses points

  • Compounded semaglutide is not FDA-approved or evaluated
  • Only available in five states (IL, IN, MI, NY, PA)
  • No tirzepatide option offered
  • Insurance not accepted for compounded semaglutide

Strengths

  • Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
  • GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
  • Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
  • Routine labs and thousands of medications included in membership — no surprise bills
  • Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide

Where it loses points

  • 10 states only (WA, NM, AZ, UT, FL, DC, KS, OK, VA, GA) — limited vs 50-state platforms
  • Membership required to access wholesale pricing — $89/mo adds ~$1,068/yr in fixed cost
  • 503A pharmacy partners not named
  • LegitScript certification not mentioned on the site
  • Medical director and corporate legal entity not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard